RSS   Newsletter   Contact   Advertise with us
Post Online Media

Novabay Pharma appoints Mark Sieczkarek president and CEO

NovaBayNovaBay Pharmaceuticals, Inc., a biopharmaceutical company, announces the appointment of Mark M. Sieczkarek as president and chief executive officer.
Article continues below

READ MORE NovaBay Pharma names chairman as interim president and CEO

Mr. Sieczkarek has been a NovaBay Director since January 2014, was named Chairman in April 2015 and has served as interim President and CEO since November 2015. He has been instrumental in the development and implementation of the go-to-market strategy for Avenova.

Mr. Sieczkarek previously was CEO of Solta Medical, Inc. (acquired by Valeant Pharmaceuticals) and of Conceptus, Inc. (acquired by Bayer HealthCare), where he led the launch of the medical device Essure.

Prior to that, he was Senior Vice President and President of The Americas and Europe for the leading ophthalmic company Bausch & Lomb (acquired by Valeant Pharmaceuticals), where he was responsible for overseeing multinational commercial launches of several leading products.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy